ABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTD
Q2 2023 Form 13-F
HONG KONG, HONG KONG
CIK 0001832108
· Institutional investment manager
$5.5M Reported Value Total
Reported value
$5.5M
Quarter over quarter
-12.6%
Holdings
3
Top-10 concentration
100.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Fan Yu
Director
Filing Navigation
13F Metrics
Loading 13F Metrics
Q2 2023 13F record
Q2 2023 13F filing summary
| Period of report | June 30, 2023 |
|---|---|
| Filed | August 14, 2023 |
| Form | 13F-HR |
| Reported value | $5.5M |
| Positions | 3 |
| Change in reported value | -13.1% |
| New positions | 0 |
| Exited positions | 0 |
| Position turnover | 0.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
2 | $8.6M |
|
Q1 2026 13F
Filed May 18, 2026
|
2 | $12.3M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
2 | $15.0M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
2 | $18.7M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
2 | $26.8M |
|
Q1 2025 13F
Filed May 15, 2025
|
4 | $38.3M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
4 | $43.7M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
3 | $20.1M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
3 | $30.0M |
|
Q1 2024 13F
Filed May 15, 2024
|
3 | $41.5M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
4 | $51.3M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
4 | $20.8M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
3 | $5.5M |
|
Q1 2023 13F
Filed May 15, 2023
|
3 | $6.3M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
3 | $6.2M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
3 | $16.0M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
3 | $28.3M |
|
Q1 2022 13F
Filed May 16, 2022
|
3 | $12.3M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
2 | $7.4M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
2 | $14.7M |
3 earlier quarters on file — choose one from the quarter menu above.
Top 3 holdings · Q2 2023
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | MDVL MEDAVAIL HOLDINGS INC | $3.7M | 66.84% |
| 2 | RPID RAPID MICRO BIOSYSTEMS INC | $1.0M | 18.84% |
| 3 | LUNG PULMONX CORP | $789.3K | 14.32% |
Values as reported on the Q2 2023 Form 13F. Every position is in the holdings table below.